Bukit Darah PLC (COSE:BUKI.N0000)
0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Bukit Darah Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 348,712 | 323,642 | 277,009 | 330,421 | 170,656 | |
Revenue Growth (YoY) | 7.75% | 16.84% | -16.16% | 93.62% | 48.64% |
Cost of Revenue | 249,849 | 236,195 | 199,659 | 241,169 | 122,215 |
Gross Profit | 98,863 | 87,447 | 77,350 | 89,252 | 48,441 |
Selling, General & Admin | 37,464 | 35,766 | 33,381 | 35,837 | 18,897 |
Other Operating Expenses | 25,082 | -1,516 | -1,653 | 780.52 | 1,014 |
Operating Expenses | 62,546 | 34,250 | 31,727 | 36,617 | 19,912 |
Operating Income | 36,317 | 53,197 | 45,623 | 52,635 | 28,530 |
Interest Expense | -3,315 | -7,800 | -14,725 | -16,670 | -7,252 |
Interest & Investment Income | - | 3,184 | 3,301 | 3,467 | 1,530 |
Earnings From Equity Investments | -33.49 | 10.9 | -12.7 | -13.79 | -34.03 |
Currency Exchange Gain (Loss) | 493.82 | 365.29 | 61.15 | -507.41 | 957.44 |
Other Non Operating Income (Expenses) | - | - | - | 2,247 | 797.6 |
EBT Excluding Unusual Items | 33,463 | 48,958 | 34,247 | 41,157 | 24,528 |
Gain (Loss) on Sale of Investments | 1,312 | 2,809 | 1,880 | 923 | -1,776 |
Gain (Loss) on Sale of Assets | - | 1,284 | 479.69 | 72.41 | 63.62 |
Asset Writedown | -4,914 | -972.76 | 681.64 | 225.48 | -498.49 |
Pretax Income | 29,861 | 52,078 | 37,288 | 42,378 | 22,318 |
Income Tax Expense | 11,056 | 17,949 | 15,087 | 15,082 | 7,725 |
Earnings From Continuing Operations | 18,804 | 34,129 | 22,202 | 27,296 | 14,593 |
Earnings From Discontinued Operations | - | - | - | 771.89 | 385.51 |
Net Income to Company | 18,804 | 34,129 | 22,202 | 28,068 | 14,978 |
Minority Interest in Earnings | -13,691 | -19,953 | -13,789 | -15,045 | -7,554 |
Net Income | 5,113 | 14,176 | 8,413 | 13,023 | 7,424 |
Preferred Dividends & Other Adjustments | 212.17 | 156.65 | 26.3 | 16.24 | 14.77 |
Net Income to Common | 4,901 | 14,019 | 8,387 | 13,007 | 7,409 |
Net Income Growth | -63.93% | 68.50% | -35.40% | 75.42% | 108.79% |
Shares Outstanding (Basic) | 102 | 102 | 102 | 102 | 102 |
Shares Outstanding (Diluted) | 102 | 102 | 102 | 102 | 102 |
Shares Change (YoY) | -0.01% | - | - | - | - |
EPS (Basic) | 48.05 | 137.44 | 82.22 | 127.52 | 72.64 |
EPS (Diluted) | 48.05 | 137.44 | 82.22 | 127.52 | 72.64 |
EPS Growth | -65.04% | 67.16% | -35.52% | 75.55% | 108.90% |
Free Cash Flow | 28,162 | 33,543 | 15,947 | 35,572 | 10,475 |
Free Cash Flow Per Share | 276.11 | 328.85 | 156.34 | 348.75 | 102.69 |
Dividend Per Share | 14.430 | 10.680 | 1.800 | 1.100 | 1.000 |
Dividend Growth | 35.11% | 493.33% | 63.64% | 10.00% | 66.67% |
Gross Margin | 28.35% | 27.02% | 27.92% | 27.01% | 28.38% |
Operating Margin | 10.42% | 16.44% | 16.47% | 15.93% | 16.72% |
Profit Margin | 1.41% | 4.33% | 3.03% | 3.94% | 4.34% |
Free Cash Flow Margin | 8.08% | 10.36% | 5.76% | 10.77% | 6.14% |
EBITDA | 48,163 | 64,507 | 56,867 | 63,679 | 35,483 |
EBITDA Margin | 13.81% | 19.93% | 20.53% | 19.27% | 20.79% |
D&A For EBITDA | 11,846 | 11,310 | 11,244 | 11,045 | 6,953 |
EBIT | 36,317 | 53,197 | 45,623 | 52,635 | 28,530 |
EBIT Margin | 10.42% | 16.44% | 16.47% | 15.93% | 16.72% |
Effective Tax Rate | 37.03% | 34.47% | 40.46% | 35.59% | 34.62% |